Table 2 % distribution of different groups of comorbidities in the whole sample and by gender
From: Prevalence of different comorbidities in COPD patients by gender and GOLD stage
Comorbidities | Overall % (n = 3,198) | Males % (n = 2,182) | Females % (n = 1,016) |
|---|---|---|---|
Cardio-Vascular | 39.0 | 44.7 | 30.7 |
Respiratory | 22.4 | 23.0 | 21.1 |
Metabolic | 10.4 | 9.2 | 12.4 |
Oncologic | 7.6 | 7.0 | 8.5 |
Neuro Psychiatric | 6.5 | 6.6 | 6.2 |
Gastro Enterologic | 8.6 | 4.8 | 14.2 |
Osteo-Articular | 4.9 | 3.8 | 6.0 |
Other | 0.6 | 0.9 | 0.9 |